-+ 0.00%
-+ 0.00%
-+ 0.00%

Whitehawk Therapeutics Q2 EPS $(0.20) Beats $(0.30) Estimate

Benzinga·08/06/2026 12:46:47
Listen to the news
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.30) by 33.33 percent. This is a 73.68 percent increase over losses of $(0.76) per share from the same period last year.